If you have been researching weight loss medications, you have probably drowned in brand names, dosages, and conflicting claims. Let me do for you what I do for every patient who sits in my office: cut through the noise and explain your options in plain, honest language — what each one is, whether it’s FDA-approved, and what the actual science shows.
I believe deeply that an informed patient makes the best decisions about her own body. So consider this your cheat sheet — the same straight talk I’d give you across the desk, backed by the landmark clinical trials (all linked at the bottom so you can read them yourself).
First, What These Medications Actually Are
The medications transforming weight care all belong to a family called incretin therapies — they work with the natural gut hormones that regulate appetite, fullness, and blood sugar. Where they differ is how many of those hormone pathways each one activates. That single distinction explains most of the difference in their results.
Option 1 — Semaglutide
Generic name: Semaglutide · Trade names: Wegovy® (for weight), Ozempic® (for diabetes) · FDA status: Approved for chronic weight management.
Semaglutide is a single agonist — it activates one pathway, GLP-1. Think of GLP-1 as the body’s “I’m satisfied” signal. By amplifying it, semaglutide reduces appetite, quiets cravings, and helps you feel full sooner and longer. It was the medication that opened the modern era of weight care.
What the science shows: In the landmark STEP 1 trial (1,961 adults, 68 weeks), participants on semaglutide lost an average of about 14.9% of their body weight, versus 2.4% on placebo — and roughly 86% lost at least 5% of their weight.
Option 2 — Tirzepatide
Generic name: Tirzepatide · Trade names: Zepbound® (for weight), Mounjaro® (for diabetes) · FDA status: Approved for chronic weight management.
Tirzepatide is a dual agonist — it activates two pathways at once: GLP-1 and GIP. Adding that second hormone tends to enhance appetite control and metabolic effect, which is why it’s sometimes called the “next step up.”
What the science shows: In the landmark SURMOUNT-1 trial (2,539 adults, 72 weeks), average weight loss was dose-dependent: about 16% at 5 mg, 21% at 10 mg, and 22.5% at 15 mg, versus 2.4% on placebo. Notably, participants lost roughly three times more fat mass than lean mass — a meaningful detail we’ll come back to.
Option 3 — Retatrutide (Investigational)
Generic name: Retatrutide (development code LY3437943) · Trade name: None yet · FDA status: Not FDA-approved. In late-stage (Phase 3) clinical trials.
Retatrutide is the one generating the most excitement in my field, and for good reason: it’s a triple agonist, activating three pathways — GLP-1, GIP, and glucagon. That third target, glucagon, is thought to increase the body’s energy expenditure (active fat-burning), not just reduce appetite.
What the science shows: In the Phase 2 NEJM trial (338 adults, 48 weeks), the highest dose produced an average weight reduction of about 24.2%, versus 2.1% on placebo — among the largest reductions reported for any obesity medication in a trial of this length. Early Phase 3 readouts have continued to look promising.
My honest, important caveat: Retatrutide is not yet approved and not available as a treatment. I include it because part of expert care is understanding where the science is heading — so that as the field evolves, your plan can evolve with it, grounded in evidence and your individual needs.
The Cheat Sheet, Side by Side
Trial averages are from controlled studies with specific eligibility criteria; individual results vary. Higher average weight loss does not automatically mean a medication is “right” for you — the best choice depends on your health, history, and goals.
The Number Almost Everyone Misses: Body Composition
Here is where I want to slow down, because this is the part most weight loss conversations get dangerously wrong. The scale is a liar. It tells you how much you weigh — not what you’re losing. And on these medications, what you lose matters enormously.
When you lose weight rapidly, a portion of that loss can be lean muscle, not just fat. That’s a problem, because muscle is your metabolic engine — it’s what keeps your metabolism strong, your body firm, and your weight loss durable. Lose too much muscle, and you set yourself up to regain the weight and feel weaker doing it. This is exactly why the SURMOUNT-1 detail — far more fat lost than lean — is so important, and why it should be measured, not assumed.
This is why, at The Optime Studio, we don’t just hand you a prescription and watch a bathroom scale. We use body composition analysis to track your fat mass and lean mass separately — so we can protect your muscle while the fat comes off. We pair your medication with the protein, resistance, and metabolic support that keep your engine strong. Losing weight is easy to claim. Losing the right weight — and keeping it off — is what real medicine delivers.
A pound of fat lost is a victory. A pound of muscle lost is a setback wearing a victory’s disguise. The scale can’t tell the difference — but body composition analysis can, and that changes everything about how we care for you.
The Truth About Compounded Medications
You may have seen “compounded” versions of these medications advertised at low prices online. Compounded medications are custom-prepared by licensed pharmacies, and in the right circumstances they can be a legitimate, more accessible option. But quality and sourcing vary enormously, and not everything marketed online is safe or appropriate.
My approach is simple: when compounding is appropriate for your situation, we work only with trusted, accredited pharmacies, and every option is chosen and monitored as part of a real, personalized medical plan — never a faceless transaction. The goal is always the same: the safest, most effective path to your goals, tailored to the whole picture of your health.
A Note on Cost, Insurance & Access
One of the most common worries I hear is about cost — and I want to be transparent and flexible here, because access shouldn’t be the reason you don’t get well. Learn more about our medical weight loss program, including pricing and insurance options. Depending on your situation, there are multiple paths, and we’ll help you find the one that fits.
Where You Come In
If you live in Jupiter, Palm Beach Gardens, Delray Beach, or anywhere in South Florida, you don’t need to decode this alone. The “best” medication isn’t the one with the biggest trial number — it’s the one that’s right for your body, your history, and your goals, guided by someone who measures what matters and adjusts your care over time. That’s the whole picture, and that’s exactly what we do. If you’re also wondering why weight loss has gotten harder with age, read our guide on why the weight won’t come off after 40.
References — Landmark Trials: (1) STEP 1 (Semaglutide): Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021. (2) SURMOUNT-1 (Tirzepatide): Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022. (3) Retatrutide Phase 2 (investigational): Jastreboff AM, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. N Engl J Med. 2023. Educational information only; not medical advice. Medication names are the property of their respective manufacturers. Retatrutide is investigational and not FDA-approved. Individual results vary.
